These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21320787)

  • 41. Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control.
    Rossmanith W; Chabicovsky M; Grasl-Kraupp B; Peter B; Schausberger E; Schulte-Hermann R
    Mol Carcinog; 2002 Sep; 35(1):1-5. PubMed ID: 12203361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activins, follistatin and immunoregulation in the epididymis.
    Wijayarathna R; Hedger MP
    Andrology; 2019 Sep; 7(5):703-711. PubMed ID: 31322318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sheng-ji Hua-yu formula promotes diabetic wound healing of re-epithelization via Activin/Follistatin regulation.
    Kuai L; Zhang JT; Deng Y; Xu S; Xu XZ; Wu MF; Guo DJ; Chen Y; Wu RJ; Zhao XQ; Nian H; Li B; Li FL
    BMC Complement Altern Med; 2018 Jan; 18(1):32. PubMed ID: 29378560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activin A and cardiovascular disease in type 2 diabetes mellitus.
    Ueland T; Aukrust P; Aakhus S; Smith C; Endresen K; Birkeland KI; Gullestad L; Johansen OE
    Diab Vasc Dis Res; 2012 Jul; 9(3):234-7. PubMed ID: 22234949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats.
    Silva RN; Bueno PG; Avó LR; Nonaka KO; Selistre-Araújo HS; Leal AM
    Braz J Med Biol Res; 2014 Sep; 47(9):746-52. PubMed ID: 25075578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of heparin administration to sheep on the release profiles of circulating activin A and follistatin.
    Jones KL; De Kretser DM; Phillips DJ
    J Endocrinol; 2004 May; 181(2):307-14. PubMed ID: 15128279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The caveolin-1 regulated protein follistatin protects against diabetic kidney disease.
    Zhang D; Gava AL; Van Krieken R; Mehta N; Li R; Gao B; Desjardins EM; Steinberg GR; Hawke T; Krepinsky JC
    Kidney Int; 2019 Nov; 96(5):1134-1149. PubMed ID: 31492508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions.
    Lerch TF; Shimasaki S; Woodruff TK; Jardetzky TS
    J Biol Chem; 2007 May; 282(21):15930-9. PubMed ID: 17409095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue absence initiates regeneration through follistatin-mediated inhibition of activin signaling.
    Gaviño MA; Wenemoser D; Wang IE; Reddien PW
    Elife; 2013 Sep; 2():e00247. PubMed ID: 24040508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Follistatin impacts Tumor Angiogenesis and Outcome in Thymic Epithelial Tumors.
    Janik S; Bekos C; Hacker P; Raunegger T; Schiefer AI; Müllauer L; Veraar C; Dome B; Klepetko W; Ankersmit HJ; Moser B
    Sci Rep; 2019 Nov; 9(1):17359. PubMed ID: 31757999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activin A/follistatin system: another link to heparin-induced osteoporosis?
    Borawski J; Naumnik B; Myśliwiec M
    Clin Appl Thromb Hemost; 2004 Apr; 10(2):191-2. PubMed ID: 15094943
    [No Abstract]   [Full Text] [Related]  

  • 52. Activin in the brain modulates anxiety-related behavior and adult neurogenesis.
    Ageta H; Murayama A; Migishima R; Kida S; Tsuchida K; Yokoyama M; Inokuchi K
    PLoS One; 2008 Apr; 3(4):e1869. PubMed ID: 18382659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure and activation of pro-activin A.
    Wang X; Fischer G; Hyvönen M
    Nat Commun; 2016 Jul; 7():12052. PubMed ID: 27373274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Follistatin as potential therapeutic target in prostate cancer.
    Sepporta MV; Tumminello FM; Flandina C; Crescimanno M; Giammanco M; La Guardia M; di Majo D; Leto G
    Target Oncol; 2013 Dec; 8(4):215-23. PubMed ID: 23456439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma follistatin concentrations increase following lipopolysaccharide administration in sheep.
    Klein R; Clarke IJ; Hedger MP; Robertson DM
    Clin Exp Pharmacol Physiol; 1996 Aug; 23(8):754-5. PubMed ID: 8886504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substantial Increases Occur in Serum Activins and Follistatin during Lung Transplantation.
    de Kretser DM; Bensley JG; Phillips DJ; Levvey BJ; Snell GI; Lin E; Hedger MP; O'Hehir RE
    PLoS One; 2016; 11(1):e0140948. PubMed ID: 26820896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pattern of activin A and follistatin release in a sheep model of cardiopulmonary bypass.
    Chen Y; Phillips DJ; McMillan J; Bedford P; Goldstein J; Wu H; Hedger MP; Smith JA
    Cytokine; 2011 May; 54(2):154-60. PubMed ID: 21320787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stimulatory effects of lipopolysaccharide on endothelial cell activin and follistatin.
    Wilson KM; Smith AI; Phillips DJ
    Mol Cell Endocrinol; 2006 Jul; 253(1-2):30-5. PubMed ID: 16697104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin.
    Jones KL; Brauman JN; Groome NP; de Kretser DM; Phillips DJ
    Endocrinology; 2000 May; 141(5):1905-8. PubMed ID: 10803603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair.
    de Kretser DM; O'Hehir RE; Hardy CL; Hedger MP
    Mol Cell Endocrinol; 2012 Aug; 359(1-2):101-6. PubMed ID: 22037168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.